Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Business

NAFDAC blacklists Indian manufacturer for falsified Ciproflaxin tablets

Omokolade Ajayi by Omokolade Ajayi
November 25, 2020
in Business
NAFDAC blacklists Indian manufacturer for falsified Ciproflaxin tablets
Share on FacebookShare on TwitterShare on Linkedin

Prof. Mojisola Christianah Adeyeye, the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), has disclosed that the agency has blacklisted Mars Remedies PVT Limited, India.

According to the press release issued, the agency blacklisted Mars Remedies PVT Limited for manufacturing falsified Ciprofloxacin Tablets BP 500mg (NAFDAC REG. NO C4-0498) for Pinnacle Health Pharmaceutical Ltd, 16/18. Nuru Oniwo Street, Surulere, Lagos.

In view of the unprofessional practice, Prof. Adeyeye explained that all products manufactured by the Indian company will not be allowed into Nigeria with immediate effect.

RelatedPosts

Lagos says 3.9km Opebi-Ojota link bridge to be ready by June 2023

Why Interpol arrested 28-year-old Nigerian in South Africa

According to Prof. Adeyeye, the variation in the formulation of the Ciprofloxacin 500mg tablets, which may impact the product quality and shelf-life, was not approved by the Agency before the changes were made.

This constitutes a violation of the NAFDAC Act, noting with dismay that the company has displayed a flagrant disregard for compliance with global standards necessary to assure the production of quality assured products. Therefore, the company has been blacklisted accordingly.

The Director-General wishes to warn all manufacturers and importers of medicines to adhere strictly to the conditions for which their products were registered by NAFDAC or face similar sanctions.

What you should know

This decision is a follow up to the notice sent to the Indian company, in a letter dated October 9, 2020 and addressed to the Managing Director of Mars Remedies PVT Limited, with the title; “Notice of blacklisting as a manufacturer of substandard and falsified medicines.”

The DG of NAFDAC, in the letter, reiterated the agency’s position of zero tolerance for substandard and falsified medicines preponderance in Nigeria, in fulfillment of the regulatory obligation to safeguard the health of the nation.

She explained that the company illegally manufactured different formulations of Ciprofloxacin tablets, instead of the approved formulation for export to Nigeria, and this is in violation of NAFDAC’s extant laws and regulations.

Related

Tags: Mars Remedies PVT LimitedNAFDACProf. Mojisola Christianah Adeyeye

Comments 1

  1. ABIMBOLA says:
    November 25, 2020 at 7:37 pm

    There must be a consequence for pinnacle action so as to serve as detriment for other company that wish to do the same either an heavy fine or court action.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Mega Millions
Hot forex
Cornerstone
Polaris Bank
Access Bank
Bankers Committee
First bank


FCMB




    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • KongaPay at House of Lords, London, signs historic partnership with Bibimoney
    • US Equities: Weekly Round up
    • Top Crypto: UST Classic leads weekly gainers of top 100

    Follow us on social media:

    Recent News

    KongaPay at House of Lords, London, signs historic partnership with Bibimoney

    KongaPay at House of Lords, London, signs historic partnership with Bibimoney

    July 3, 2022
    U.S Stocks set to surge higher, on hopes of a stimulus package deal, What Does The Circuit Breaker Tell Us

    US Equities: Weekly Round up

    July 3, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com